January 06, 2025 05:43 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow
Sinopharm
Image Credit: wikipedia.org

China's Sinopharm Covid-19 vaccine gets WHO's nod for emergency use

| @indiablooms | May 08, 2021, at 04:50 am

Geneva/IBNS: The World Health Organisation (WHO) on Friday gave emergency use approval for a coronavirus vaccine made by China's state-owned drug manufacturer Sinopharm, said a Reuters report.

The vaccine is one of the two shots made by China and has been exported to several countries and given to millions of people in China, according to the report.

It is also the first vaccine made by a non-western country to get the UN health body's approval and also the first Chinese vaccine to get its nod for any infectious disease, the report said.

This draws significance as WHO's approval is a benchmark of safety and efficacy of a product for countries. It also means that the Chinese vaccine can now be included in COVAX, the programme to make available coronavirus vaccine to poor countries across the globe.

Johnson & Johnson, AsyraZeneca, Pfizer-BioNTech and Moderna have so far received approval for emergency use from WHO.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.